Search the Newsreel

HRMY or ACAD: Which Is the Better Value Stock Right Now?

Investors looking for stocks in the Medical - Biomedical and Genetics sector might want to consider either Harmony Biosciences Holdings, Inc. (HRMY) or Acadia Pharmaceuticals (ACAD). But which of these two stocks presents investors with the better value opportunity right now? Let's take a …

Should Value Investors Buy Harmony Biosciences (HRMY) Stock?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks. Considering these trends, …

Harmony Biosciences Holdings Inc (HRMY) Valuation: PE, PB & Fair Value Analysis

Harmony Biosciences Holdings Inc (HRMY) has a current valuation score of 8.09, placing it 108th out of 155 in the Pharmaceuticals industry. The company's P/E ratio stands at 14.19, which is significantly below its recent high and above its recent low. Key valuation metrics …

Zacks.com featured highlights include Harmony Biosciences, Invesco, General Motors, Hewlett Packard and Quanex Building

This Zacks.com article highlights five undervalued price-to-book stocks: Harmony Biosciences, Invesco, General Motors, Hewlett Packard Enterprise, and Quanex Building Products. It explains the P/B ratio as a tool for identifying undervalued stocks, defining book value and its calculation, and discusses the importance of comparing …

Harmony Biosciences Holdings, I (HRMY) Stock Forecasts

Argus has lowered its target price for Harmony Biosciences Holdings Inc (HRMY) to $38.00. The company is a commercial-stage pharmaceutical firm specializing in therapies for rare neurological diseases. The current price of HRMY stock is $35.86.

HRMY|Harmony Biosciences Holdings Inc|Price:35.138|Chg%:-0.722

Harmony Biosciences Holdings Inc (HRMY) shows strong fundamentals, high growth potential, and is considered fairly valued within the Pharmaceuticals industry. The company's revenue has grown significantly, and it boasts high profit growth and institutional confidence. Analysts have rated the stock as "Buy" with an …

BlackRock (HRMY holder) discloses 6.53M Harmony Biosciences shares in 13G/A

BlackRock, Inc. has filed an amended Schedule 13G/A revealing a beneficial ownership of 6,525,663 shares of Harmony Biosciences Holdings, Inc. common stock, which represents an 11.3% stake in the company. BlackRock exercises sole voting power over 6,445,523 shares and sole dispositive power over all …

A Junior Just Pulled Rock Grading Double the Historical Numbers From a Nevada Tungsten District the U.S. Badly Needs

Issued on behalf of Western Star Resources Inc. (CSE: WSR) (OTC: WSRIF) (FRA: 42K) American News Group News Commentary VANCOUVER, BC, July 28, 2026 /PRNewswire/ -- The United States has not mined tungsten domestically at any meaningful scale in roughly a decade, and China …

Harmony Biosciences Holdings, Inc. (HRMY) Reports Next Week: Wall Street Expects Earnings Growth

Harmony Biosciences Holdings, Inc. (HRMY) is expected to report a year-over-year increase in earnings and revenues for the quarter ended June 2026, with Wall Street anticipating $0.97 EPS and $252.54 million in revenue. The company holds a Zacks Rank of #1 (Strong Buy) and …

Harmony Gold (NYSE: HMY) closes oversubscribed multi-currency loan package

Harmony Gold Mining Company Limited has successfully secured new syndicated, multi-tranche, multi-currency loan facilities totaling US$500 million, A$500 million, and R7 billion. These facilities are significantly oversubscribed, reflecting strong lender confidence, and will reduce funding costs, extend the debt maturity profile, and strengthen liquidity. …

US Is Reportedly Weighing Critical Minerals Price Floor – MP, USAR, UAMY, TMC Stocks Gain Pre-Market

The U.S. is reportedly developing a critical minerals price-floor system to strengthen supply chains for resources deemed vital to national security and reduce reliance on China. This proposed pricing mechanism, discussed with allies and partners, aims to unlock private investment and stabilize markets. Shares …

Harmony Biosciences Holdings Inc (HRMY) Income Statement

This article provides the quarterly and annual income statements for Harmony Biosciences Holdings Inc (HRMY), offering detailed financial data such as total revenue, operating expenses, net income, and earnings per share. It also includes key financial metrics and answers frequently asked questions about analyzing …

Neurocrine Gears Up to Report Q2 Earnings: What's in the Cards?

Neurocrine Biosciences NBIX is scheduled to report second-quarter 2026 results on July 30, after market close. We expect investors to focus on the sales performance of NBIX's marketed products and other pipeline updates when the company reports quarterly results. The Zacks Consensus Estimate for …

Harmony Biosciences Holdings Inc

This article provides key financial data for Harmony Biosciences Holdings Inc (HRMY), including its market capitalization of $2.08 billion and a P/E TTM of 14.25. It shows the company's revenue breakdown by region, with $868.45 million from the United States, but notes that detailed …

United States Antimony Corp (UAMY) Shareholder Structure: Major Shareholders & Institutional Holdings

This article provides a detailed breakdown of the shareholder structure of United States Antimony Corp (UAMY), listing major institutional holders and their percentage of shares. It includes institutional shareholding trends over several quarters and highlights recent shareholder activity with changes in holdings for key …

Harmony Gold Mining Co. Ltd (HAM) Q4 2025 Earnings Report - Results, Call & Slides

Harmony Gold Mining Co. Ltd (HAM) reported its Q4 2025 earnings, meeting EPS expectations with €0.50 and beating revenue forecasts with €1.90 billion, a 31.74% year-over-year increase. The company's next earnings report is estimated for August 27, 2026.

ETFs Investing in Harmony Gold Mining Co. Ltd. Sponsored ADR Stocks

This article lists various ETFs that include Harmony Gold Mining Co. Ltd. (HMY) Sponsored ADR stocks in their portfolios. It provides a detailed table outlining fund symbols, market values, weightings, issuers, management styles, expense ratios, AUM, price changes, and 3-year NAV total returns for …

Did CFO Exit and Reaffirmed 2026 Guidance Just Shift Harmony Biosciences' (HRMY) Investment Narrative?

Harmony Biosciences (HRMY) recently announced the departure of its CFO, Glenn Reicin, and the appointment of an interim CFO. Despite this leadership change, the company reaffirmed its full-year 2026 net product revenue guidance of US$1.00 billion to US$1.04 billion, indicating continued confidence in its …

Harmony Gold Mining Co. Ltd. Sponsored ADR Revenue Breakdown – HAM:HAM

Harmony Gold Mining Co. Ltd. Sponsored ADR (HAM) generated 3.55 billion EUR in revenue last year. The Mponeng segment was the top performer, contributing 751.59 million EUR, an increase from the previous year. The majority of the revenue, 2.94 billion EUR, originated from South …

Mony Group PLC Revenue Breakdown – LSE:MONY

MONY Group plc 2026 Q2 - Results - Earnings Call Presentation (OTCMKTS:MNSKY) 2026-07-21

Key Points Interested in Mony Group Plc? Here are five stocks we like better. Mony Group reported stronger first-half 2026 results, with like-for-like revenue up 6% to GBP 227 million and adjusted EBITDA up 3% to GBP 76 million. The company also said it …

United States Antimony Corp (UAMY) Institutional Confidence

United States Antimony Corp (UAMY) currently holds an institutional shareholding score of 5.00, ranking 48th in the Metals & Mining industry. Its institutional shareholding proportion has grown by 57.48% quarter-over-quarter to 60.79%. Paul Tudor Jones is the largest institutional shareholder, holding 191.56K shares, representing …

China Harmony Auto Holding Limited Revenue Breakdown – HKEX:3836

Matrimony.com Ltd. Revenue Breakdown – NSE:MATRIMONY

HMY|Harmony Gold Mining Company Ltd|Price:15.870|Chg%:+0.380

Harmony Gold Mining Company Ltd (HMY) has strong fundamentals and significant growth potential, although its valuation is considered fairly valued within the Metals & Mining industry. The stock price is currently trading sideways, with analysts rating it as 'Hold' and a high institutional ownership. …

HRMY|Harmony Biosciences Holdings Inc|Price:35.780|Chg%:+0.920

Harmony Biosciences Holdings Inc. (HRMY) shows strong fundamentals with high revenue and profit growth, despite its stock trading sideways recently. The company, focused on rare neurological diseases, has a "Buy" rating from analysts with a target price of $44.91, and its valuation is considered …

ETFs Investing in Harmony Biosciences Holdings, Inc. Stocks

This article lists various ETFs that currently hold Harmony Biosciences Holdings, Inc. (HRMY) stocks, providing detailed information such as market value, weight, issuer, management style, focus, expense ratio, AUM, price, change percentage, relative volume, and 3-year total return. The ETFs mainly focus on small-cap …

Harmony Biosciences (HRMY) Says Goodbye To Its CFO And Names An Interim Finance Chief

Get insights on thousands of stocks from the global community of over 7 million individual investors at Simply Wall St. Harmony Biosciences Holdings (NasdaqGM:HRMY) announced that Chief Financial Officer Glenn Reicin has resigned. The company named Stephen Mollichella as interim Principal Financial Officer, effective …

High court interdicts man over defamatory Whatsapp messages against Harmony Gold

The High Court in Johannesburg has issued an interdict against Frederik Johannes van As, preventing him from publishing false and defamatory statements against Harmony Gold. The ruling found that Van As's claims about Harmony Gold being responsible for Eskom disconnecting electricity to Deelkraal Village …

Harmony Biosciences (HRMY) officer details stock and option holdings

Stephen M. Mollichella, "INT PRINCIAL FINANCIAL OFFICER" at Harmony Biosciences (HRMY), has reported his initial beneficial ownership on a Form 3 filing. The filing details his holdings in stock options, restricted stock units, and directly owned common stock. These holdings include various vesting schedules …

Harmony Biosciences interim principal financial officer Stephen Mollichella files initial beneficial ownership statement

Stephen Mollichella, interim principal financial officer of Harmony Biosciences, has filed his initial beneficial ownership statement (Form 3). The filing indicates he holds 2,506 common shares, stock options for 48,472 shares with exercise prices between $30.69 and $38.01, and 12,013 restricted stock units. This …

Barometer Capital Management Inc. Grows Position in Harmony Gold Mining Company Limited $HMY

Barometer Capital Management Inc. significantly increased its stake in Harmony Gold Mining Company Limited (NYSE:HMY) by 1,118.8% in the first quarter, bringing its total holdings to 117,000 shares valued at $1.76 million. Other institutional investors also adjusted their positions, with hedge funds and institutions …

Harmony Biosciences (HRMY) Soars 10.0%: Is Further Upside Left in the Stock?

Harmony Biosciences (HRMY) shares surged 10% after the company reported stronger-than-expected preliminary second-quarter 2026 results, with Wakix net product revenue reaching a record $261 million. The company reaffirmed its full-year 2026 revenue guidance of $1.0 billion to $1.04 billion, driven by robust demand and …

UAMY: United States Antimony Corp. Latest Stock Price, Analysis, News and Trading Ideas

This article provides the latest stock price, analysis, news, and trading ideas for United States Antimony Corp. (UAMY). It includes real-time stock data, fundamental metrics, recent news headlines related to the company, and discussions about other trending stocks. The information is presented in a …

Harmony Biosciences Holdings Jumps 9.6% Amid Sector-Wide Rally

Harmony Biosciences (HRMY) shares surged 9.6% following a broad rally across the biotechnology sector. The increase brought the company's shares to $36.73, with trading volume reaching 1.2M shares. This sector-wide momentum, rather than company-specific news, appears to be the primary driver for the gains, …

United States Antimony CEO to be Featured on Fox Business

United States Antimony Corporation (USAC) announced that its Chairman and CEO, Mr. Gary C. Evans, will be featured live on Fox Business's "Mornings with Maria Bartiromo" on October 22, 2025. Mr. Evans will discuss the company's 10% ownership and proposed acquisition of an additional …